ConforMIS, Inc. Announces Election of Philip W. Johnston to its Board of Directors
Mar 31, 2017 12:30 pm UTC| Business
BEDFORD, Mass., March 31, 2017 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2016 Financial Results
Mar 31, 2017 12:30 pm UTC| Business
CHARLOTTESVILLE, Va., March 31, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
Mar 31, 2017 12:22 pm UTC| Business
VIENNA, Austria and NEW YORK, March 31, 2017 -- Nasdaq BWise (Nasdaq:NDAQ), a global leader in enterprise Governance, Risk Management and Compliance (GRC), announced today that it has been selected by Erste Group, one...
Mar 31, 2017 12:14 pm UTC| Business
TULSA, Okla., March 31, 2017 -- Midstates Petroleum Company, Inc.(“Midstates” or the “Company”) (NYSE MKT:MPO)today announced the Company will participate in IPAA's 23rd Annual Oil Gas Investment Symposium (OGIS) on...
Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights
Mar 31, 2017 12:05 pm UTC| Business
NEW YORK and CLEVELAND, March 31, 2017 -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases,...
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
Mar 31, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, March 31, 2017 -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases,...
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
Mar 31, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, March 31, 2017 -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases,...
US–India Trade Talks Race Toward USD 500 Billion Goal